শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে

ইঙ্গিত

Oxaliplat, given together with infusional 5-fluorouracil and folinic acid, is indicated for the adjuvant treatment of stage III colon cancer in patients who have had the primary tumour completely removed by surgery, and for the treatment of advanced colorectal cancer.

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

ফার্মাকোলজি

Oxaliplatin converts nonenzymatically in body fluids to its active form once its labile oxalate group is displaced. This process forms several short-lived reactive species, including monoaquo and diaquo DACH platinum, which bind covalently to macromolecules. The drug forms both interstrand and intrastrand platinum-DNA crosslinks, joining the N7 positions of two adjacent guanines (GG), adjacent adenine-guanine pairs (AG), or guanines separated by an intervening nucleotide (GNG). These crosslinks block DNA replication and transcription, and the resulting cytotoxic effect is not specific to any phase of the cell cycle. In animal studies, oxaliplatin has shown activity against colon carcinoma. When combined with 5-fluorouracil, it produces greater antiproliferative effects, both in laboratory and animal studies, than either agent used alone, an effect seen across several tumor models, including HT29 (colon), GR (mammary), and L1210 (leukemia).

Pregnancy & Breastfeeding

Pregnancy Category D. Oxaliplatin may cause fetal harm when given to a pregnant woman, and there are no adequate, well-controlled studies of the drug in pregnant women. Women who could become pregnant should be advised to avoid pregnancy while receiving oxaliplatin treatment. It is not known whether oxaliplatin or its derivatives pass into human breast milk. Since many drugs are excreted in breast milk, and because nursing infants could face serious adverse effects from oxaliplatin, a decision should be made to discontinue either nursing or the drug, weighing how important the treatment is to the mother.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: Oxaliplatin is given together with 5-fluorouracil and folinic acid, with the cycle repeated every 2 weeks. In advanced disease, treatment is recommended to continue until the disease progresses or side effects become unacceptable. When used as adjuvant treatment, the recommended course lasts a total of 6 months (12 cycles). Day 1: Oxaliplatin 85 mg/m² is given as an intravenous infusion in 250 to 500 mL of 5% Dextrose Injection, USP, and folinic acid 200 mg/m² is given as an intravenous infusion in 5% Dextrose Injection, USP. Both are infused over 120 minutes at the same time, in separate bags connected through a Y-line. This is followed by 5-fluorouracil 400 mg/m² as an intravenous bolus over 2 to 4 minutes, and then 5-fluorouracil 600 mg/m² as an intravenous infusion in 500 mL of 5% Dextrose Injection, USP (recommended), given as a continuous infusion over 22 hours. Day 2: Folinic acid 200 mg/m² is given as an intravenous infusion over 120 minutes. This is followed by 5-fluorouracil 400 mg/m² as an intravenous bolus over 2 to 4 minutes, and then 5-fluorouracil 600 mg/m² as an intravenous infusion in 500 mL of 5% Dextrose Injection, USP (recommended), given as a continuous infusion over 22 hours.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.

প্রধান পারস্পরিক ক্রিয়া

Checker →